Annual Working Capital
$167.82 M
+$94.01 M+127.37%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual working capital is $167.82 million, with the most recent change of +$94.01 million (+127.37%) on December 31, 2023.
- During the last 3 years, DNTH annual working capital has risen by +$163.78 million (+4058.08%).
- DNTH annual working capital is now at all-time high.
Performance
DNTH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$271.78 M
-$83.88 M-23.58%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly working capital is $271.78 million, with the most recent change of -$83.88 million (-23.58%) on September 30, 2024.
- Over the past year, DNTH quarterly working capital has increased by +$93.41 million (+52.36%).
- DNTH quarterly working capital is now -26.93% below its all-time high of $371.97 million, reached on March 31, 2024.
Performance
DNTH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DNTH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.4% | +52.4% |
| 3 y3 years | +4058.1% | +52.4% |
| 5 y5 years | +4058.1% | +52.4% |
DNTH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4058.1% | -26.9% | +268.2% |
| 5 y | 5-year | at high | +4058.1% | -26.9% | +268.2% |
| alltime | all time | at high | +4058.1% | -26.9% | +268.2% |
Dianthus Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $271.78 M(-23.6%) |
| Jun 2024 | - | $355.66 M(-4.4%) |
| Mar 2024 | - | $371.97 M(+121.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $167.82 M(+127.4%) | $167.82 M(-5.9%) |
| Sep 2023 | - | $178.37 M(+141.7%) |
| Dec 2022 | $73.81 M(+1728.7%) | $73.81 M |
| Dec 2021 | $4.04 M | - |
FAQ
- What is Dianthus Therapeutics annual working capital?
- What is the all time high annual working capital for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual working capital year-on-year change?
- What is Dianthus Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly working capital year-on-year change?
What is Dianthus Therapeutics annual working capital?
The current annual working capital of DNTH is $167.82 M
What is the all time high annual working capital for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual working capital is $167.82 M
What is Dianthus Therapeutics annual working capital year-on-year change?
Over the past year, DNTH annual working capital has changed by +$94.01 M (+127.37%)
What is Dianthus Therapeutics quarterly working capital?
The current quarterly working capital of DNTH is $271.78 M
What is the all time high quarterly working capital for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly working capital is $371.97 M
What is Dianthus Therapeutics quarterly working capital year-on-year change?
Over the past year, DNTH quarterly working capital has changed by +$93.41 M (+52.36%)